Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y X Feng

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Science Advances|May 16, 2019
Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T<sub>reg</sub> cellsM Feng, J Q Jin, L Xia, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|March 27, 2002
Serum- and glucocorticoid-dependent kinase, cell volume, and the regulation of epithelial transportS Fillon, S Wärntges, J Matskevitch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2018
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerE S Sokol, Y X Feng, D X Jin, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Science Advances|May 16, 2019
Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T<sub>reg</sub> cellsM Feng, J Q Jin, L Xia, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|March 27, 2002
Serum- and glucocorticoid-dependent kinase, cell volume, and the regulation of epithelial transportS Fillon, S Wärntges, J Matskevitch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2018
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerE S Sokol, Y X Feng, D X Jin, et al.
Pageof 6